Sites in the body that do not normally contain bacteria, such as the blood, lung fluid or cerebrospinal fluid (CSF) are said to be sterile. When these sites are infected, and the sterility is thus com [..]

The term “vaccine pipeline” identifies vaccines currently in research and under development. In addition, the vaccine pipeline is divided into temporal, sequential phases of developing, testing and pr [..]

A conjugate vaccine contains an antigen (the immunity producing molecule) bound to a carrier protein (which will allow the antigen access to areas of a cell where the carrier protein may go). These va [..]

A

The Accelerated Development and Introduction Plans (ADIPs) address the significant technical, epidemiological and financial challenges involved in making new vaccines available that are to be used pri [..]

Adjuvants are agents commonly added to a vaccine formulation which do not stimulate an immunologic response alone but can help to increase the immune response to other components of a vaccine or stimu [..]

An Advance Market Commitment (AMC) is an innovative financing mechanism with the potential to save millions of lives by accelerating access to vaccines that would not otherwise be available for many y [..]

The small, branched air-containing pockets of the lungs where oxygen inhaled during respiration passes through a thin membrane and into the blood stream. Carbon dioxide passes across these thin membra [..]

An agent – either chemically synthesized or isolated from fungi or other organisms – that kills outright, or is detrimental to, the growth of bacteria.

A protein found in the blood that is produced by specialized cells of the immune system (B cells) in response to foreign substances (e.g. bacteria or viruses) invading the body. Antibodies protect the [..]